OraVerse for Children

The Children’s Dental Health Center Introduces OraVerse™

Your child’s comfort is an important priority in our practice. So if you’re child doesn’t like the lingering numbness of local anesthesia and the way it can limit daily activities, an innovative solution is here. The Children’s Dental Health Center is pleased to offer a new product called OraVerse™.

OraVerse is the first and only product of its kind to rapidly reverse the effects of local anesthetics so you can feel, speak, smile, and drink normally in approximately half the time. OraVerse is not recommended for use in children less than 6 years of age or weighing less than 15 kg (33 lbs).

For more information, you can visit www.OraVerse.com.

Important Safety Information
Tachycardia, bradycardia, and cardiac arrhythmias may occur with the use of phentolamine or other alpha-adrenergic blocking agents. Although such effects are uncommon with OraVerse (phentolamine mesylate), clinicians should be alert to the signs and symptoms of these events, particularly in patients with a history of cardiovascular disease. Following parenteral use of phentolamine at doses between 5 to 15 times higher than the recommended dose of OraVerse, myocardial infarction, and cerebrovascular spasm and occlusion have been reported, usually in association with marked hypotensive episodes producing shock-like states.